مباشر
FierceBiotechPredicta links with Spanish university to offer diagnostic for blood cancersBioPharma DiveSummit pulls $500M share sale a day after announcing itEndpoints NewsDrugmakers are turning to logistics providers as trade disruptions linger, DHL exec saysBioPharma DiveSensorion, citing Regeneron competition, shifts focus to a different hearing loss therapyEndpoints NewsSummit withdraws $500M offering, citing 'market conditions'BioWorldScore in phase I CML trial has Enliven looking ahead to phase IIIClinical OMICsLipid-Protein Biomarker Makes Clinical Debut with Early Ovarian Cancer DetectionEndpoints NewsSensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophyEndpoints NewsCamurus’ second CRL for acromegaly drug; Teva details workforce cutsFierceBiotechFierce Biotech heading to UK to host event amid London Life Sciences WeekBioPharma DiveNovartis RNA drug acquired in $12B Avidity deal notches a trial winEndpoints NewsBiopharma pay report: Top-paid CSOs, CMOs of 2025
BioWorld ٢٧ نوفمبر ٢٠٢٥

Brenig Therapeutics discovers new LRRK2 inhibitors

Brenig Therapeutics discovers new LRRK2 inhibitors

المصدر
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.